Using berberine in combination with other therapeutic agents may enhance its hepatic protective effects, potentially leading to better patient outcomes [157,158,159,160,161,162,163,164,165,166,167]
Originally FDA-approved as a Type 2 diabetes treatment, Semaglutide has shown significant promise in recent clinical trials, STEP 1 and STEP 3, for weight loss
For diabetes, NICE recommends continuing treatment if HbA1c reduces by at least 11 mmol/mol (1.0%) and weight decreases by at least 3% at 6 months
Proper Semaglutide Injection Technique and Site Selection PlexusDx recommends injecting compounded semaglutide into the abdomen, upper arm, or thighareas with adequate subcutaneous fat and lower nerve density
A peptide acts throughout the body, touching several systems at once